• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical and epidemiological profile of ST-segment elevation myocardial infarction patients in a megacity of west of Iran.伊朗西部一个大城市中ST段抬高型心肌梗死患者的临床和流行病学特征
Health Sci Rep. 2023 May 5;6(5):e1187. doi: 10.1002/hsr2.1187. eCollection 2023 May.
2
A cross-sectional study determining prevalence and factors associated with ST-segment elevation myocardial infarction and non-ST segment elevation myocardial infarction in Iran: results from fasa registry on acute myocardial infarction (FaRMI).一项横断面研究,旨在确定伊朗 ST 段抬高型心肌梗死和非 ST 段抬高型心肌梗死的流行情况和相关因素:来自急性心肌梗死的 Fasa 注册研究(FaRMI)的结果。
BMC Public Health. 2024 Mar 6;24(1):728. doi: 10.1186/s12889-024-18140-6.
3
Assessment of the management of acute myocardial infarction patients and their outcomes at the Nairobi Hospital from January 2007 to June 2009.对2007年1月至2009年6月内罗毕医院急性心肌梗死患者的管理及其治疗结果的评估。
Cardiovasc J Afr. 2016 Jul/Aug;27(4):218-221. doi: 10.5830/CVJA-2015-091.
4
ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?无标准可调节心血管风险因素的 ST 段抬高型心肌梗死(STEMI)患者——他们有多常见,其结局如何?
J Am Heart Assoc. 2019 Nov 5;8(21):e013296. doi: 10.1161/JAHA.119.013296. Epub 2019 Nov 1.
5
Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction.ST 段抬高型与非 ST 段抬高型心肌梗死后的指南遵循情况
Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):654-61. doi: 10.1161/CIRCOUTCOMES.111.963959. Epub 2012 Sep 4.
6
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.非标准可调节风险因素的 STEMI 患者的死亡率:SWEDEHEART 注册研究数据的性别细分分析。
Lancet. 2021 Mar 20;397(10279):1085-1094. doi: 10.1016/S0140-6736(21)00272-5. Epub 2021 Mar 9.
7
Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors.越来越多的 ST 段抬高型心肌梗死患者的冠状动脉粥样硬化程度不能用标准的可改变的危险因素来很好地解释。
Eur J Prev Cardiol. 2017 Nov;24(17):1824-1830. doi: 10.1177/2047487317720287. Epub 2017 Jul 13.
8
Sex-Related Differences in Short- and Long-Term Outcome among Young and Middle-Aged Patients for ST-Segment Elevation Myocardial Infarction Underwent Percutaneous Coronary Intervention.性别对中青年 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗短期和长期结局的影响。
Chin Med J (Engl). 2018 Jun 20;131(12):1420-1429. doi: 10.4103/0366-6999.233965.
9
[Clinical characteristics and prognosis of young (<35 years) patients with acute ST-segment elevation myocardial infarction].[年轻(<35岁)急性ST段抬高型心肌梗死患者的临床特征与预后]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Nov 24;49(11):1124-1129. doi: 10.3760/cma.j.cn112148-20210805-00672.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Prognostic value of NT-proBNP and uric acid in acute ST-segment elevation myocardial infarction patients after complete revascularization.NT-proBNP和尿酸在急性ST段抬高型心肌梗死患者完全血运重建后的预后价值
Am J Transl Res. 2024 Aug 15;16(8):4182-4189. doi: 10.62347/VQWS9174. eCollection 2024.
2
Global prevalence of sexual dysfunction in cardiovascular patients: a systematic review and meta-analysis.心血管病患者性功能障碍的全球患病率:系统评价和荟萃分析。
Syst Rev. 2024 May 20;13(1):136. doi: 10.1186/s13643-024-02525-0.

本文引用的文献

1
Acute coronary syndromes.急性冠状动脉综合征。
Lancet. 2022 Apr 2;399(10332):1347-1358. doi: 10.1016/S0140-6736(21)02391-6.
2
STEMI care 2021: Addressing the knowledge gaps.2021年ST段抬高型心肌梗死护理:填补知识空白
Am Heart J Plus. 2021 Nov;11:100044. doi: 10.1016/j.ahjo.2021.100044. Epub 2021 Aug 25.
3
Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock.ST段抬高型心肌梗死合并心原性休克患者的种族、民族和性别差异。
JACC Cardiovasc Interv. 2021 Mar 22;14(6):653-660. doi: 10.1016/j.jcin.2021.01.003.
4
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
5
Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study.缺血性心脏病的全球流行病学:全球疾病负担研究结果
Cureus. 2020 Jul 23;12(7):e9349. doi: 10.7759/cureus.9349.
6
Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka.斯里兰卡一家三级护理医院收治的不同类型急性冠脉综合征患者的流行病学和危险因素。
BMC Cardiovasc Disord. 2019 Oct 21;19(1):229. doi: 10.1186/s12872-019-1217-x.
7
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.世界卫生组织心血管疾病风险图表:修订后的模型可估算 21 个全球区域的风险。
Lancet Glob Health. 2019 Oct;7(10):e1332-e1345. doi: 10.1016/S2214-109X(19)30318-3. Epub 2019 Sep 2.
8
Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention.伊朗过去 40 年的心血管疾病:患病率、死亡率、发病率、心血管疾病预防的挑战和策略。
Arch Iran Med. 2019 Apr 1;22(4):204-210.
9
The first survey of the Saudi Acute Myocardial Infarction Registry Program: Main results and long-term outcomes (STARS-1 Program).沙特急性心肌梗死注册研究计划的首次调查:主要结果和长期预后(STARS-1 计划)。
PLoS One. 2019 May 21;14(5):e0216551. doi: 10.1371/journal.pone.0216551. eCollection 2019.
10
Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease.性别差异和糖尿病对冠状动脉粥样硬化及缺血性心脏病的影响
J Clin Med. 2019 Jan 16;8(1):98. doi: 10.3390/jcm8010098.

伊朗西部一个大城市中ST段抬高型心肌梗死患者的临床和流行病学特征

Clinical and epidemiological profile of ST-segment elevation myocardial infarction patients in a megacity of west of Iran.

作者信息

Janjani Parisa, Motevaseli Sayeh, Salimi Yahya, Bavandpouri Sousan Mahmoudi, Ziapour Arash, Salehi Nahid, Karami Sahar

机构信息

Cardiovascular Research Center, Health Research Institute, Imam Ali Hospital Kermanshah University of Medical Sciences Kermanshah Iran.

Student Research Committee, Kermanshah University of Medical Sciences Kermanshah Iran.

出版信息

Health Sci Rep. 2023 May 5;6(5):e1187. doi: 10.1002/hsr2.1187. eCollection 2023 May.

DOI:10.1002/hsr2.1187
PMID:37152229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10161763/
Abstract

BACKGROUND AND AIMS

Low- and middle-income nations account for at least three-quarters of cardiovascular disease deaths worldwide. This study aimed to obtain real knowledge about ST segment elevation myocardial infarction (STEMI) patients and provide the context for developing a principles for care quality improvement.

METHOD

This cross-sectional study was conducted from July 2018 through December 2019. The study sample consisted of1169 eligible patients based on inclusion criteria. The data were collected using the standard EROP and three specialized, trained questionnaires. The collected data were checked by the quality control officer and analyzed using Stata Version 14.

RESULTS

Patient baseline characteristics showed that body mass index, low-density lipoprotein, high-density lipoprotein, total cholesterol, and triglyceride levels were higher in women. Also, females recorded a considerable history of diabetes mellitus, hypertension, and hypercholesterolemia compared to men. The results also showed that most men were smokers (46.80%). Aspirin (94.27%), statins (91.48%), and clopidogrel (90.68%) were the common medications used at hospital discharge for patients.

CONCLUSION

The present study suggests that identifying and managing modifiable risk factors can improve cardiovascular disease outcomes. Also, considering the early identification of STEMI patients with new therapies can effectively decrease the rate of cardiovascular disease and its attributed health outcomes.

摘要

背景与目的

低收入和中等收入国家的心血管疾病死亡人数至少占全球的四分之三。本研究旨在获取关于ST段抬高型心肌梗死(STEMI)患者的真实情况,并为制定护理质量改进原则提供背景依据。

方法

本横断面研究于2018年7月至2019年12月进行。根据纳入标准,研究样本包括1169名符合条件的患者。数据通过标准的EROP以及三份经过专门培训的问卷进行收集。收集到的数据由质量控制人员进行检查,并使用Stata 14版本进行分析。

结果

患者基线特征显示,女性的体重指数、低密度脂蛋白、高密度脂蛋白、总胆固醇和甘油三酯水平较高。此外,与男性相比,女性患糖尿病、高血压和高胆固醇血症的病史更为显著。结果还显示,大多数男性为吸烟者(46.80%)。阿司匹林(94.27%)、他汀类药物(91.48%)和氯吡格雷(90.68%)是患者出院时常用的药物。

结论

本研究表明,识别和管理可改变的风险因素可改善心血管疾病的预后。此外,考虑采用新疗法早期识别STEMI患者可有效降低心血管疾病的发生率及其相关健康后果。